Skip to main content

Carles Rubio Maturana

I am Carles Rubio Maturana, pre-doctoral researcher in the Microbiology group at VHIR. I work at the Centre de Salut Internacional i malalties transmissibles Drassanes-Vall d'Hebron. I am doing research in the field of clinical microbiology and artificial intelligence for diagnosis.

Institutions of which they are part

Research technician
Microbiology
Vall Hebron Institut de Recerca

Carles Rubio Maturana

Institutions of which they are part

Research technician
Microbiology
Vall Hebron Institut de Recerca

I am Carles Rubio Maturana, pre-doctoral researcher in the Microbiology group at VHIR. I work at the Centre de Salut Internacional i malalties transmissibles Drassanes-Vall d'Hebron. I am doing research in the field of clinical microbiology and artificial intelligence for diagnosis.

I studied Biotechnology at the Faculty of Biology at the University of Barcelona. I have a Master's degree in Nanotechnology and Nanoscience from the Faculty of Physics at the University of Barcelona.
I have taken courses in Artificial Intelligence at the Universitat Politènica de Catalunya, where I am also an associate professor in the Physics Department.
I have been doing research at IBMB-CSIC and at the Institute of Nanoscience and Nanotechnology IN2UB for almost 2 years.
I am currently working at VHIR and studying for my PhD at the Universitat Autònoma de Barcelona.

Projects

AcToVax4NAM - Increased Access To Vaccination for Newly Arrived Migrants

IP: Nuria Serre Delcor
Collaborators: Victoria Lopez Lopez, Susana Nuria Ayala Cortes, Patricia Martinez Vallejo, Carles Rubio Maturana
Funding agency: EUROPEAN COMMISSION
Funding: 94759.2
Reference: ACTOVAX4NAM_CHAFEA/HP-PJ-2020
Duration: 01/05/2021 - 30/04/2024

Related news

The new diagnostic method, designed for use in endemic regions, combines a mobile application with a low-cost robotic microscope.

The European network EUPertStrain celebrates its annual meeting, focused on the study of the evolution of Bordetella pertussis, the bacterium responsible for this disease that can be very serious in children under one year.

The Vall d'Hebron work has shown that people vaccinated with Pfizer or Moderna have specific memory T lymphocytes against SARS-CoV-2 in the lung months after vaccination.

Related professionals

M. Helena  Closa Castells

M. Helena Closa Castells

Psychiatry, Mental Health and Addictions
Read more
Franky Vargas, Enrique

Franky Vargas, Enrique

Research technician
Molecular Medical Imaging
Read more
Aroa Soriano Fernández

Aroa Soriano Fernández

Main researcher
Childhood Cancer and Blood Disorders
Read more
Giustiniani , Alessandro

Giustiniani , Alessandro

Predoctoral researcher
Cardiovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.